Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Signaling mechanisms regulating myelination in the central nervous system.
Control of Human PLP1 Expression Through Transcriptional Regulatory Elements and Alternatively Spliced Exons in Intron 1.
[Co-authorship and collaboration networks in Spanish research into multiple sclerosis (1996-2010)].
Multiple Sclerosis and the Iranian Revolution: Reply to the Comment by Magzhi et al..
Aquaporin-4 autoimmunity masquerading as a brainstem tumor.
Autoimmune Thyroid Disease in the Use of Alemtuzumab for Multiple Sclerosis: A Review.
Physiological evidence for diversification of IFNα- and IFNβ-mediated response programs in different autoimmune diseases.
Synaptic signal streams generated by ex vivo neuronal networks contain non-random, complex patterns.
Medication possession ratio: implications of using fixed and variable observation periods in assessing adherence with disease-modifying drugs in patients with multiple sclerosis.
Meningeal inflammation and demyelination in a patient clinically diagnosed with acute disseminated encephalomyelitis.
Ecological validity of walking capacity tests in multiple sclerosis.
Investigation of outer cortical magnetisation transfer ratio abnormalities in multiple sclerosis clinical subgroups.
The potential role of pharmacogenomics in the prevention of serious adverse drug reactions in multiple sclerosis.
Relapsing inappropriate antidiuretic hormone secretion in an anti-aquaporin-4 antibody positive paediatric patient.
Osmotic demyelination syndrome in Intensive Care Unit.
Venous Hemodynamic Insufficiency Severity Score variation after endovascular treatment of chronic cerebrospinal venous insufficiency.
Improving communication with multiple sclerosis patients.
Benign-onset acute disseminated encephalomyelitis: a report on two cases.
Quantitative analysis of the suppressors of cytokine signaling 1 and 3 in peripheral blood leukocytes of patients with multiple sclerosis.
Level of education and multiple sclerosis risk after adjustment for known risk factors: The EnvIMS study.
Demyelinating disorders secondary to TNF-inhibitor therapy for the treatment of psoriasis: A review.
Cannabinoids: Medical implications.
Microwave & magnetic (M(2) ) proteomics of the EAE animal model of multiple sclerosis.
Pro-Inflammatory Cytokines Reduce the Proliferation of NG2 Cells and Increase Shedding of NG2 In Vivo and In Vitro.
Diagnostic tools for assessment of urinary dysfunction in MS patients without urinary disturbances.
Pages
« first
‹ previous
…
432
433
434
435
436
437
438
439
440
…
next ›
last »